His company, G Medical Innovations, is based in Israel, but has since listed on the ASX, and was one of the reasons why Dr Geva was in town last year.
As noted in my previous article, G Medical Innovations offers "a suite of consumer and professional clinical-grade products (regulatory approved) that are positioned to streamline healthcare services, improve remote access to medical data, reduce costs, improve quality of care, and make healthcare more personalised and precise".
The company also offers a "professional real-time patient continuous monitoring solution", dubbed the G Medical Patch (GMP), a video of which is also in the article linked just above.
Now comes news that Prizma is available for direct order by consumers online with the launch of the Prizma online store, here.
Article continues below image, please read on.
The launch marks the first time that the Prizma will be made available to consumers for direct purchase in countries where it has been approved by the regulatory authorities (including Australia, as noted further below), thereby "enabling users to monitor and receive immediate and real-time medical measurements, view their medical trends and share test results with any third party".
The Prizma can transform any compatible smartphone into a medical monitoring device. The Prizma has received approvals from regulatory authorities such as the FDA and TGA, and has also been approved for CE marking.
So, what can the Prizma do more specifically?
It is "able to monitor a range of biometric measurements with the ability to provide and transmit real-time results and present medical data to detect trends over time. The device currently measures 1-lead ECG, heart rate, temperature and oxygen saturation".
"Users can create an individual patient profile via a dedicated user portal, and can share their tests results with caregivers, medical professionals, and anyone else nominated by the patient.
"The Prizma uses a friendly app available for download from the Apple App Store or Google Play, through which the user can then track and monitor their vital signs."
Dr Geva said, “Launching our online store and making Prizma accessible to individuals provides consumers with the opportunity to transform personal healthcare and self-monitoring, giving Prizma users more control over their health and enabling caregivers to have direct communication with their patients."
For those in the US, the Prizma medical smartphone case is available there only with a physician's prescription.
As noted above, G Medical Innovations received approval in November 2017 from both the Therapeutics Goods Administration (TGA), as well as certification by the New Zealand Medicines and Medical Devices Safety Authority (MEDSAFE) for its Prizna Medical Smartphone Case.
It was yet another significant milestone for the company, whereby the Prizma now officially complies with all relevant Australian and New Zealand medical and safety requirements as a Class IIa Medical device.
These certifications have effectively meant that the PRIZMA can be made available over the counter as a medical device throughout Australia, New Zealand and additional countries accepting TGA and MEDSAFE certifications.
These additional certifications also added to the previously granted approvals for the PRIZMA by U.S Food and Drug Administration (FDA) 510(K), as well as the European ‘CE’ Class IIa approval, effectively opening up the Global Market for the PRIZMA.
Naturally, with these additional certifications in place, the company has been able to expedite the ongoing commercial discussions with its potential partners on new agreements.
Commenting on the Approvals at the time, Dr Geva said: “Being granted TGA and MEDSAFE certification allows, in particularly for our Australian shareholders, to fully appreciate the tremendous opportunity at hand for our Company, in providing necessary and unmet medically graded solutions for the monitoring, management and collection of an enormous pool of data for chronic illnesses; as well as providing disruptive and highly cost effective and scalable solutions for the greater healthcare and hospital ecosystems worldwide."
You can watch a video interview conducted with Dr Geva by iTWire, as well as videos on Prizma and the GMP here.